Transplantation in AML

Steven Lane

Clinical haematologist and translational researcher at the Royal Brisbane and Women’s Hospital and QIMR Berghofer Medical Research Institute
Director of Clinical Research in Cancer Care at RBWH
Head of the Cancer Program at QIMR Berghofer
Lab head of the Gordon and Jessie Gilmour Leukaemia Research Lab.

Jump to:
Please wait...
phototonyphillips.com
Steven Lane is a clinical haematologist and translational researcher at the Royal Brisbane and Women’s Hospital and QIMR Berghofer Medical Research Institute. His clinical work has a specific focus on myeloid blood cancers such as AML, MDS and myeloproliferative neoplasm. He is the Director of Clinical Research in Cancer Care at RBWH, and investigator on a number of national cooperative trials. He is the Head of the Cancer Program at QIMR Berghofer, and lab head of the Gordon and Jessie Gilmour Leukaemia Research Lab.
Scroll to top

Enter the serial number on your certificate to access the GET Weekend archive of the various lectures!

For medical enquiries please contact 1800 671 203 (ph.)
or medinfo.phauno@novartis.com (email)

Novartis Pharmaceuticals Australia Pty Limited. ABN: 18 004 244 160
54 Waterloo Road, Macquarie Park NSW 2113. AU-9334 May 2019